Cancer Nanotheranostics
After a quarter of century of express technological advances, research has publicized the convolution of cancer, a disease confidentially related to the dynamic transformation of the genome. It is here that Nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. Nanotechnology offers numerous tools to diagnose and treat cancer, such as new imaging agents, multifunctional devices capable of overcome biological barriers to deliver therapeutic agents directly to cells and tissues involved in cancer growth and metastasis, and devices capable of predicting molecular changes to prevent action against precancerous cells. Nanomaterials-based delivery systems in Theranostics (Diagnostics & Therapy) provide better penetration of therapeutic and diagnostic substances within the body at a reduced risk in comparison to conventional therapies. At the present time, there is a growing need to enhance the capability of theranostics procedures where nanomaterials-based sensors may provide for the simultaneous detection of several gene-associated conditions and nanodevices with the ability to monitor real-time drug action. These innovative multifunctional nanocarriers for cancer theranostics may allow the development of diagnostics systems such as colorimetric and immunoassays, and in therapy approaches through gene therapy, drug delivery and tumor targeting systems in cancer.
- Cancer Microenvironment
- Stealth Nanoparticles and Tumour Penetrating Peptides
- Photothermal and Photodynamic therapies
- Ferrofluid and magnetic hyperthermia
- New Nanomaterials
- Imaging and Cancer Theranostics
- Advances in Nanotechnology for cancer treatment
- Translational Nanomedicines
- Cancer Diagnostics
Related Conference of Cancer Nanotheranostics
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Ljubljana Slovenia
ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia
21st to 23rd January 2016
Miami Florida United States of America
Miami 2016 Winter Symposium Miami United States of America
24th to 27th January 2016
Penang Malaysia
2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia
26th to 28th January 2016
Berlin Germany
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany
5th to 6th February 2016
Pune Maharashtra India
3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India
5th to 7th February 2016
Hyderabad Telangana India
New and Emerging Trends In Oncology 2016 Hyderabad India
10th to 12th February 2016
Mumbai India
International Conference on Radiation Research Impact on Human Health and Environment Mumbai India
11th to 13th February 2016
Singapore
3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore
22nd to 23rd February 2016
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
San Francisco CA United States of America
Molecular Medicine Tri-Con 2016 San Francisco United States of America
6th to 11th March 2016
Ljubljana Slovenia
ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia
21st to 23rd January 2016
Miami Florida United States of America
Miami 2016 Winter Symposium Miami United States of America
24th to 27th January 2016
Penang Malaysia
2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia
26th to 28th January 2016
Berlin Germany
Global Engage s Biologics Congress Berlin Germany
1st to 2nd February 2016
Berlin Germany
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany
5th to 6th February 2016
Pune Maharashtra India
3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India
5th to 7th February 2016
Mumbai India
International Conference on Radiation Research Impact on Human Health and Environment Mumbai India
11th to 13th February 2016
Singapore
3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore
22nd to 23rd February 2016
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
San Francisco CA United States of America
Molecular Medicine Tri-Con 2016 San Francisco United States of America
6th to 11th March 2016
Ljubljana Slovenia
ESSO-EYSAC Course on Colorectal Cancer Surgery
21st to 23rd January 2016
Miami Florida United States of America
Miami 2016 Winter Symposium
24th to 27th January 2016
Penang Malaysia
2nd AMDI International Biohealth Sciences Conference
26th to 28th January 2016
Berlin Germany
Global Engage s Biologics Congress
1st to 2nd February 2016
Berlin Germany
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach
5th to 6th February 2016
Pune Maharashtra India
3rd International Conference on Biotechnology and Bioinformatics
5th to 7th February 2016
Hyderabad India
New and Emerging Trends In Oncology
10th to 12th February 2016
Mumbai India
International Conference on Radiation Research Impact on Human Health and Environment
11th to 13th February 2016
Singapore
3rd Annual International Conference on Advances in Cancer Medical Research
22nd to 23rd February 2016
Kuala Lumpur Malaysia
The Probiotics Congress Asia
29th February to 1st March 2016
San Francisco CA United States of America
Molecular Medicine Tri-Con
6th to 11th March 2016
Cancer Nanotheranostics Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)